El Anciano en La Unidad De Cuidados Intensivos
Creator
López-Soto, Alfonso
Sacanella, Emilio
Pérez Castejón, Juan Manuel
Nicolás, José M
Bibliographic Citation
Revista española de geriatría y gerontología 2009 Jun; 44 Suppl 1: 27-33
Abstract
Admission of elderly patients to intensive care units (ICU) is an increasing phenomenon. The severity of the disease causing admission and the basal functional patient's status are conditions more important than age to predict mortality and long term functional outcome. Studies demonstrate that elderly ICU survivors recover after discharge the majority part of their functional capability and perception of quality of life. On the contrary, these patients develop higher number of geriatric syndromes, mainly confusional syndrome. The culture of geriatric comprehensive assessment should be implemented in ICU and especially after discharge. The use of simple and validates scales (Barthel's Index, Lawton's Index and EuroQol-5D...) must be incorporated into the clinical practice. This is a good tool that could be useful for the specialists involved in the usually difficult decision of whether an elderly patient should or not be admitted to an ICU.
Permanent Link
http://hdl.handle.net/10822/1027917Full Text from Publisher
Date
2009-06Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 Testing in Gastric Carcinoma
Gómez-Martín, Carlos; Concha, Angel; Corominas, José María; García-Caballero, Tomás; García-García, Elena; Iglesias, Mar; López, José Antonio; Ramón y Cajal, Santiago; Rojo, Federico; Palacios, José; Vera-Sempere, Francisco; Aranda, Enrique; Colomer, Ramon; García-Alfonso, Pilar; Garrido, Pilar; Rivera, Fernando; López-Ríos, Fernando (Spanish Society of Medical Oncology; Spanish Society of Pathology, 2011-09)The identification of HER2 alterations in advanced gastric carcinomas is of critical importance in daily clinical practice as such neoplasms require specific treatment with trastuzumab. For these reasons, pathologists and ...